Domestic pharmaceutical industry calls for overhaul of new drug pricing policy

Published: 2002-09-17 07:00:00

Updated: 2002-09-17 07:00:00

Many pharmaceutical firms is strongly opposing the projected drug price re-evaluation system that the government intends to introduce from this September 1, saying that the new system will lead to a tremendous damage to the pharmaceutical industry following a series of price reduction of drugs in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK